These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 32424064)

  • 1. Serum neurofilament light chain and optical coherence tomography measures in MS: A longitudinal study.
    Tavazzi E; Jakimovski D; Kuhle J; Hagemeier J; Ozel O; Ramanathan M; Barro C; Bergsland N; Tomic D; Kropshofer H; Leppert D; Michalak Z; Lincoff N; Dwyer MG; Benedict RHB; Weinstock-Guttman B; Zivadinov R
    Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32424064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Serum Neurofilament Light Chain With Inner Retinal Layer Thinning in Multiple Sclerosis.
    Sotirchos ES; Vasileiou ES; Filippatou AG; Fitzgerald KC; Smith MD; Lord HN; Kalaitzidis G; Lambe J; Duval A; Prince JL; Mowry EM; Saidha S; Calabresi PA
    Neurology; 2022 Aug; 99(7):e688-e697. PubMed ID: 35618438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis.
    Petzold A; Balcer LJ; Calabresi PA; Costello F; Frohman TC; Frohman EM; Martinez-Lapiscina EH; Green AJ; Kardon R; Outteryck O; Paul F; Schippling S; Vermersch P; Villoslada P; Balk LJ;
    Lancet Neurol; 2017 Oct; 16(10):797-812. PubMed ID: 28920886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of serum markers with optical coherence tomography angiography for evaluating neuromyelitis optica spectrum disorders and multiple sclerosis.
    Liu C; Zhou W; Sun X; Zhang X; Xiao H; Yang H; Lin H; Lu Y; Liu Z; Qiu W; Kermode AG; Yang X; Wang Y
    Mult Scler Relat Disord; 2024 May; 85():105478. PubMed ID: 38457885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Serum Neurofilament Light and Thin Ganglion Cell-Inner Plexiform Layer Are Additive Risk Factors for Disease Activity in Early Multiple Sclerosis.
    Lin TY; Vitkova V; Asseyer S; Martorell Serra I; Motamedi S; Chien C; Ditzhaus M; Papadopoulou A; Benkert P; Kuhle J; Bellmann-Strobl J; Ruprecht K; Paul F; Brandt AU; Zimmermann HG
    Neurol Neuroimmunol Neuroinflamm; 2021 Sep; 8(5):. PubMed ID: 34348969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of optical coherence tomography inter-eye percentage difference for optic neuritis in multiple sclerosis.
    Coric D; Balk LJ; Uitdehaag BMJ; Petzold A
    Eur J Neurol; 2017 Dec; 24(12):1479-1484. PubMed ID: 28887838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trans-synaptic degeneration in the optic pathway: Exploring the role of lateral geniculate nucleus in early stages of relapsing-remitting multiple sclerosis.
    Miante S; Margoni M; Moretto M; Pengo M; Carmisciano L; Spolettini P; Silvestri E; Danieletto M; Franciotta S; Miscioscia A; Bertoldo A; Puthenparampil M; Gallo P
    Mult Scler Relat Disord; 2023 Sep; 77():104877. PubMed ID: 37454566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis optic neuritis and trans-synaptic pathology on cortical thinning in people with multiple sclerosis.
    Ganapathy Subramanian R; Zivadinov R; Bergsland N; Dwyer MG; Weinstock-Guttman B; Jakimovski D
    J Neurol; 2023 Aug; 270(8):3758-3769. PubMed ID: 37067590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual deficits and cognitive assessment of multiple sclerosis: confounder, correlate, or both?
    Jakimovski D; Benedict RHB; Weinstock-Guttman B; Ozel O; Fuchs TA; Lincoff N; Bergsland N; Dwyer MG; Zivadinov R
    J Neurol; 2021 Jul; 268(7):2578-2588. PubMed ID: 33590339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis.
    Puthenparampil M; Federle L; Poggiali D; Miante S; Signori A; Pilotto E; Rinaldi F; Perini P; Sormani MP; Midena E; Gallo P
    PLoS One; 2017; 12(8):e0183957. PubMed ID: 28850630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers.
    Coric D; Balk LJ; Verrijp M; Eijlers A; Schoonheim MM; Killestein J; Uitdehaag BM; Petzold A
    Mult Scler; 2018 Feb; 24(2):158-166. PubMed ID: 28273785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of spectral domain optical coherence tomography measurements in optic neuritis: differences in neuromyelitis optica, multiple sclerosis, isolated optic neuritis and normal healthy controls.
    Park KA; Kim J; Oh SY
    Acta Ophthalmol; 2014 Feb; 92(1):e57-65. PubMed ID: 23889747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal study.
    Jakimovski D; Kuhle J; Ramanathan M; Barro C; Tomic D; Hagemeier J; Kropshofer H; Bergsland N; Leppert D; Dwyer MG; Michalak Z; Benedict RHB; Weinstock-Guttman B; Zivadinov R
    Ann Clin Transl Neurol; 2019 Sep; 6(9):1757-1770. PubMed ID: 31437387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shortened Pattern Electroretinogram Latency and Impaired Autoregulatory Dynamics to Steady-State Stimuli in Patients With Multiple Sclerosis.
    Jiang H; Gameiro GR; Hu H; Monsalve PF; Dong C; Hernandez J; Delgado SR; Porciatti VD; Wang J
    J Neuroophthalmol; 2021 Mar; 41(1):60-68. PubMed ID: 31977664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical coherence tomography angiography measurements in multiple sclerosis: a systematic review and meta-analysis.
    Mohammadi S; Gouravani M; Salehi MA; Arevalo JF; Galetta SL; Harandi H; Frohman EM; Frohman TC; Saidha S; Sattarnezhad N; Paul F
    J Neuroinflammation; 2023 Mar; 20(1):85. PubMed ID: 36973708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study.
    Balk LJ; Cruz-Herranz A; Albrecht P; Arnow S; Gelfand JM; Tewarie P; Killestein J; Uitdehaag BM; Petzold A; Green AJ
    J Neurol; 2016 Jul; 263(7):1323-31. PubMed ID: 27142714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis.
    Narayanan D; Cheng H; Bonem KN; Saenz R; Tang RA; Frishman LJ
    Mult Scler; 2014 Sep; 20(10):1331-41. PubMed ID: 24639478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macular ganglion cell-inner plexiform layer defect patterns in multiple sclerosis patients without optic neuritis: A Spectral-Domain-Optical Coherence Tomography Cross-Sectional, Case-Control, Pilot Study.
    Albano V; Dammacco R; Manni A; Sisto D; Iaffaldano A; Mavilio A; Alessio G; Trojano M; Paolicelli D
    Eur J Ophthalmol; 2023 Jan; 33(1):546-555. PubMed ID: 35799453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using Fourier-domain optical coherence tomography.
    Monteiro ML; Fernandes DB; Apóstolos-Pereira SL; Callegaro D
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3959-66. PubMed ID: 22589446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripapillary retinal nerve fiber layer thickness measured by optical coherence tomography in different clinical subtypes of multiple sclerosis.
    Jankowska-Lech I; Wasyluk J; Palasik W; Terelak-Borys B; Grabska-Liberek I
    Mult Scler Relat Disord; 2019 Jan; 27():260-268. PubMed ID: 30423530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.